The BURAN Study of Buparlisib (AN2025) In Combination With Paclitaxel Compared to Paclitaxel Alone, in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Grants and Contracts Details

StatusActive
Effective start/end date7/20/214/19/23

Funding

  • Syneos Health LLC: $28,143.00